|Bid||2,901.00 x 0|
|Ask||2,910.00 x 0|
|Day's Range||2,912.82 - 2,920.99|
|52 Week Range||26.62 - 3,450.61|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-14.78%|
|Beta (5Y Monthly)||1.05|
|Expense Ratio (net)||0.65%|
SAN CLEMENTE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended March 31, 2022. First Quarter 2022 Results First quarter 2022 revenue was $543.1 million, compared to $318.0 million in the same period last year. GAAP gross profit for the first quarter of 2022 was $168.8 million, as compared to $112.7 million in the same period last year.
It might be of some concern to shareholders to see the ICU Medical, Inc. ( NASDAQ:ICUI ) share price down 11% in the...